Literature DB >> 22754420

Acute kidney injury in the setting of knee arthroplasty: a case report and discussion investigating Angiotensin-converting enzyme inhibitors as the culprit.

Andrew J Rosenbaum, Jason A Luciano, Robert Marburger, Eric Hume.   

Abstract

Total knee arthroplasty (TKA) has become the predominant treatment modality for severe degenerative joint disease. With recent advancements in surgical and anesthetic technique, patients with severe comorbidities are able to have this procedure; they would have been precluded from TKA only a matter of years ago. Although many studies have investigated risk factors and the causes of perioperative morbidity and mortality in the arthroplasty patient, few have linked risk factors with specific outcomes. We present a case report that illustrates the link between the use of angiotensin-converting enzyme inhibitors and the development of postoperative acute kidney injury. While this relationship has been extensively studied in cardiac and gastric bypass patient populations, it has never been examined in the setting of joint replacement.

Entities:  

Keywords:  acute kidney injury (AKI); angiotensin-converting enzyme inhibitor (ACE-I); total knee arthroplasty (TKA)

Year:  2011        PMID: 22754420      PMCID: PMC3145861          DOI: 10.1007/s11420-010-9189-5

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  21 in total

1.  Thirty-day mortality after total knee arthroplasty.

Authors:  J Parvizi; T A Sullivan; R T Trousdale; D G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2001-08       Impact factor: 5.284

2.  Total joint arthroplasty: When do fatal or near-fatal complications occur?

Authors:  Javad Parvizi; Alan Mui; James J Purtill; Peter F Sharkey; William J Hozack; Richard H Rothman
Journal:  J Bone Joint Surg Am       Date:  2007-01       Impact factor: 5.284

3.  Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis.

Authors:  Camilo Restrepo; Javad Parvizi; Thomas Dietrich; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2007-06       Impact factor: 5.284

4.  The Frank Stinchfield Award. Sudden death during primary hip arthroplasty.

Authors:  J Parvizi; A D Holiday; M H Ereth; D G Lewallen
Journal:  Clin Orthop Relat Res       Date:  1999-12       Impact factor: 4.176

5.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

Review 6.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

7.  Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function.

Authors:  Charuhas V Thakar; Sarah Worley; Susana Arrigain; Jean-Pierre Yared; Emil P Paganini
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

8.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

Review 9.  An overview of drug-induced acute kidney injury.

Authors:  Neesh Pannu; Mitra K Nadim
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

10.  Mortality following primary total knee arthroplasty.

Authors:  Gurdev S Gill; David Mills; Atul B Joshi
Journal:  J Bone Joint Surg Am       Date:  2003-03       Impact factor: 5.284

View more
  1 in total

1.  Greater Rates of Acute Kidney Injury in African American Total Knee Arthroplasty Patients.

Authors:  Tanner N Womble; John D King; Dustin H Hamilton; Max A Shrout; Cale A Jacobs; Stephen T Duncan
Journal:  J Arthroplasty       Date:  2019-01-31       Impact factor: 4.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.